ALYSSA DEHUT: Open Payments
NPI 1821510173 · SALEM, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$958 in 42 payments from 15 companies in 2025. Trend: 2023 $799 · 2024 $523 · 2025 $958
Food & beverage: $669Education: $289
| Company | Payments | Amount |
|---|---|---|
| SEAGEN INC. | 3 | $289 |
| PFIZER INC. | 21 | $143 |
| Janssen Biotech, Inc. | 2 | $132 |
| Janssen Scientific Affairs, LLC | 3 | $128 |
| Gilead Sciences, Inc. | 2 | $36 |
| Immunocore Limited | 1 | $34 |
| Astellas Pharma US Inc | 1 | $33 |
| ACCORD HEALTHCARE, INC. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| Incyte Corporation | 1 | $22 |
Products named: DARZALEX, RYBREVANT, PADCEV, Trodelvy, KIMMTRAK, Vyloy, XTANDI, Camcevi.
Industry payments across OR — which companies pay providers there.
